CD274 and neoplasm: Since tumor cells evade the cytotoxic T-cell-response by surface expression of modulatory checkpoint proteins, immunohistochemistry (IHC) for PD-L1 expression on tumor and/or immune cells has been proven to be a prognostic biomarker for the response to checkpoint inhibition [12].